Study Conduct

Symbiodx, Cure Forward partner on precision medicine

Wednesday, September 30, 2015

Symbiodx, a molecular reference laboratory in the Pacific Northwest, and Cure Forward, a Cambridge, Mass.-based, multisided technology platform to support patient engagement, are collaborating to advance precision medicine. The partnership will provide patients with streamlined access to their genomic data and greater exposure to relevant clinical trials.

[Read More]

WCG, PCCTC partner to improve oncology research reviews

Tuesday, September 29, 2015

WIRB-Copernicus Group (WCG), a provider of regulatory and ethical review services and software to support clinical research, and the Prostate Cancer Clinical Trials Consortium (PCCTC), a multicenter clinical research organization specializing in cutting-edge prostate cancer research, have formed a new partnership to enhance the quality and efficiency of the consortium’s research review process.

[Read More]

NIH awards funding for junior faculty training

Friday, September 25, 2015

To encourage junior faculty at African academic institutions to pursue research careers, the NIH is awarding up to $36.5 million over five years in the next phase of the Medical Education Partnership Initiative (MEPI). Sub-Saharan Africa bears almost a quarter of the global disease burden, yet has only 3% of the world’s health workforce, according to the World Health Organization.

[Read More]

DREAM Challenge winners announced

Wednesday, September 23, 2015

Winners have been announced for the Prostate Cancer DREAM Challenge, the first research challenge in prostate cancer to marry crowdsourcing with data sharing, paving a new way to tackle key research questions about metastatic castration-resistant prostate cancer (mCRPC), an advanced form of the disease with poor outcomes.

[Read More]

Study: Mobile healthcare app use surging

Friday, September 18, 2015

The number of mobile health applications available to consumers now surpasses 165,000, as developers incorporate innovative data collection features linked to sensors and wearables, according to a new report released by the IMS Institute for Healthcare Informatics. While most available apps focus on overall wellness, healthcare systems and professionals are expressing greater interest and excitement in broader app use as barriers to mainstream adoption of mHealth are removed—especially in the area of chronic disease management.

[Read More]

Optimal Strategix Group launches study matching app

Wednesday, September 16, 2015

Optimal Strategix Group (OSG), based in Newtown, Pa., has launched its CAVII app, available for download in the Apple App Store. CAVII is an iOS-based clinical study matching and analytics platform. Ushering in a new era of patient engagement, CAVII’s aim is to revolutionize clinical studies through the use of analytics for superior patient matching. Through CAVII, clinical studies could become more cost-effective, efficient and ultimately more engaging and insightful for patients and clinicians.

[Read More]

Certara, Paidion Research partner on pediatric drug development

Friday, September 11, 2015

Certara, a global biosimulation technology-enabled drug development company, and Paidion Research, a Durham, N.C.-based pediatric CRO, have partnered to promote more efficient and reliable drug development for pediatric patients. The partnership harnesses Certara’s biosimulation (modeling and simulation) and regulatory writing capabilities with Paidion’s regulatory strategy and pediatric clinical trial management expertise to address the critical challenges of bringing new therapies to children.

[Read More]

goBalto joins SCRS as GIP

Wednesday, September 9, 2015

San Francisco-based goBalto, a provider of cloud-based clinical study startup solutions, has announced a two-year partnership with the Society for Clinical Research Sites (SCRS), a global trade organization fully dedicated to representing the interests of clinical research sites. goBalto will participate as a Global Impact Partner (GIP), a relationship designed to facilitate critical dialogue between industry stakeholders and clinical research sites.

[Read More]